DepoCyt (Sigma-Tau Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the DepoCyt drug offered from Sigma-Tau Pharmaceuticals, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sigma-Tau Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Cytarabine |
| SUBSTANCE NAME: | CYTARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRATHECAL |
| DOSAGE FORM: | INJECTION, LIPID COMPLEX |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-10-22 |
| END MARKETING DATE: | 0000-00-00 |
DepoCyt HUMAN PRESCRIPTION DRUG Details:
| Item Description | DepoCyt from Sigma-Tau Pharmaceuticals, Inc. |
| LABELER NAME: | Sigma-Tau Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/5mL) |
| START MARKETING DATE: | 2010-10-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57665-331_50ec5ad3-a2a9-4806-919d-809978aa6b28 |
| PRODUCT NDC: | 57665-331 |
| APPLICATION NUMBER: | NDA021041 |
Other CYTARABINE Pharmaceutical Manufacturers / Labelers:
